TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1933707

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 gel (0.5 mg in 2.5 mL)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Placebo gel (2.5 mL)
Number of subjects: 397
Study: 7141686

Group type: EXPERIMENTAL
Intervention: Live influenza A/Victoria/75 (H3N2) recombinant virus vaccine with ts‐1[E] (38 degrees C shut‐off temperature)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Live influenza A/Victoria/75 (H3N2) recombinant virus vaccine with ts‐1A2 (37 degrees C shut‐off temperature)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Live influenza A/Victoria/75 (H3N2) recombinant virus vaccines with cold‐adapted A/Ann Arbor/6/60
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Live influenza A/Victoria/75 (H3N2) recombinant virus vaccines
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Wild-type A/Victoria/75 virus challenge in vaccinated volunteers
Number of subjects: 50

Group type: COMPARATOR
Intervention: Unvaccinated volunteers with little or no serum antibody
Number of subjects: 50
Study: 4056259

Group type: EXPERIMENTAL
Intervention: Dp standardized extract
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo extract
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 31125720

Group type: EXPERIMENTAL
Intervention: Valveless insufflation system at IAP 10 mm Hg
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Valveless insufflation system at IAP 15 mm Hg
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard insufflation at IAP 10 mm Hg
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard insufflation at IAP 15 mm Hg
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Valveless insufflation (both pressures)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard insufflation (both pressures)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Both systems
Number of subjects: 132
Study: 29461654

Group type: EXPERIMENTAL
Intervention: Structured aerobic and resistance exercise program performed twice per week, including 20 minutes of aerobic exercise, 20-25 minutes of resistance exercise, and 10 minutes of cool down.
Number of subjects: 18
Study: 28178072

Group type: EXPERIMENTAL
Intervention: 100 mg diclofenac + 1.2 mg atropine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo + 1.2 mg atropine
Number of subjects: 100

Group type: COMPARATOR
Intervention: 100 mg diclofenac + placebo
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo + placebo
Number of subjects: 100
Study: 25793927

Group type: EXPERIMENTAL
Intervention: Magazine article endorsing non-medicalized birth (celebrity or non-celebrity endorsement)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Organic eating (control)
Number of subjects: 180
Study: 24392486

Group type: EXPERIMENTAL
Intervention: FRC+PFC (photopolymerized in one step)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: FRC+FR (photopolymerized in one step)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: FRC+PFC (photopolymerized individually)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: FRC+FR (photopolymerized individually)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: FRC (photopolymerized)+intermediate adhesive resin and PFC (photopolymerized in one step)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: FRC (photopolymerized)+intermediate adhesive resin and FR (photopolymerized in one step)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Multidirectional FRC groups (g to l)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Unidirectional FRC groups (a to f)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Thermogravimetric analysis (TGA)
Number of subjects: 144
Study: 21180658

Group type: EXPERIMENTAL
Intervention: Glucocorticoid administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 0
Study: 19026301

Group type: EXPERIMENTAL
Intervention: Remote Ischemic Preconditioning (RIPC)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control
Number of subjects: 184
Study: 16791287

Group type: EXPERIMENTAL
Intervention: AdVEGF121 gene transfer via mini-thoracotomy
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (maximum medical treatment)
Number of subjects: 67
Study: 12589536

Group type: EXPERIMENTAL
Intervention: NIV with helmet (group H) for 1 hour, flow-triggered pressure support 10 cmH(2)O, PEEP 5 cmH(2)O, FiO(2) 0.21
Number of subjects: 10

Group type: COMPARATOR
Intervention: NIV with facial mask (group M) for 1 hour, flow-triggered pressure support 10 cmH(2)O, PEEP 5 cmH(2)O, FiO(2) 0.21
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: NIV with helmet (group H)
Number of subjects: 10

Group type: COMPARATOR
Intervention: NIV with facial mask (group M)
Number of subjects: 10
Study: 11053711

Group type: EXPERIMENTAL
Intervention: Ross operation (pulmonary autograft in aortic position)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 32
Study: 9113547

Group type: EXPERIMENTAL
Intervention: Closed suction drains after total knee arthroplasty
Number of subjects: 88

Group type: COMPARATOR
Intervention: No closed suction drains after total knee arthroplasty
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Closed suction drains after total hip arthroplasty
Number of subjects: 88

Group type: COMPARATOR
Intervention: No closed suction drains after total hip arthroplasty
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Closed suction drains
Number of subjects: 88

Group type: COMPARATOR
Intervention: No closed suction drains
Number of subjects: 88
Study: 8211453

Group type: EXPERIMENTAL
Intervention: Sulphur dioxide (SO2) challenge in apple juice
Number of subjects: 37

Group type: COMPARATOR
Intervention: Apple juice alone (control)
Number of subjects: 37
Study: 3542942

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (100 mg bd for five days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Trimethoprim (200 mg bd for five days)
Number of subjects: 40
Study: 30445718

Group type: EXPERIMENTAL
Intervention: High protein (HP) dietary guidelines
Number of subjects: 27

Group type: COMPARATOR
Intervention: Medium protein (MP) dietary guidelines
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Whole group (both HP and MP)
Number of subjects: 27
Study: 27473760

Group type: EXPERIMENTAL
Intervention: Responsiveness Index (RI) monitoring
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: Online education programme
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: Sedation-analgesia quality feedback
Number of subjects: 881
Study: 24826474

Group type: EXPERIMENTAL
Intervention: Anterior transpedicular screw-plate system (Group A)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Vertebral body screw-plate system (Group B)
Number of subjects: 16
Study: 22697452

Group type: EXPERIMENTAL
Intervention: Parent‐Child Interaction Therapy (PCIT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 28
Study: 21036569

Group type: EXPERIMENTAL
Intervention: Trained tutors
Number of subjects: 20

Group type: COMPARATOR
Intervention: Untrained tutors (control group)
Number of subjects: 20
Study: 17889864

Group type: EXPERIMENTAL
Intervention: Laser-assisted hatching (opening zona pellucida using an infrared optical laser system on the day of embryo transfer)
Number of subjects: 1386

Group type: COMPARATOR
Intervention: Control (intact zona pellucida)
Number of subjects: 1386

Group type: EXPERIMENTAL
Intervention: Laser-assisted hatching
Number of subjects: 1386
Study: 16735966

Group type: EXPERIMENTAL
Intervention: gliclazide
Number of subjects: 30

Group type: COMPARATOR
Intervention: glibenclamide
Number of subjects: 30
Study: 12823643

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (81 mg)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: B-vitamins (folic acid 2 mg and vitamin B12 1 mg)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins (vitamin E 500 mg and vitamin C 200 mg)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 10910802

Group type: EXPERIMENTAL
Intervention: 15 mg of hydrocortisone
Number of subjects: 22

Group type: COMPARATOR
Intervention: 1 mg/kg of ovine CRH
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 22
Study: 8955969

Group type: EXPERIMENTAL
Intervention: Terbutaline (5 mg in 2 ml normal saline)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Normal saline (4 ml)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Sterile water iv instead of fentanyl
Number of subjects: 131

Group type: COMPARATOR
Intervention: Atropine (0.01 mg.kg-1, iv)
Number of subjects: 131
Study: 1287983

Group type: EXPERIMENTAL
Intervention: Judgement of squareness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Judgement of circularity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspect ratio discrimination threshold
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspect ratio discrimination threshold for rectangles and ellipses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aftereffect produced by adapting to rectangles of (a/b)ADAPT equal to 1.5, 1.0 and (1/1.5)
Number of subjects: 0
Study: 3837132

Group type: EXPERIMENTAL
Intervention: Prostin 15-M (8.92 ml, 28h 30' for group A; 8.23 ml, 23h 23' for group B; 4.97 ml, 16h for group C)
Number of subjects: 470
Study: 31740859

Group type: EXPERIMENTAL
Intervention: Mulligan sustained natural apophyseal glides mobilization
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mulligan sustained natural apophyseal glides mobilization with thoracic postural correction techniques
Number of subjects: 40
Study: 28462869

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) given for 5 months in blended form (face-to-face and web-based sessions)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 120
Study: 27507989

Group type: EXPERIMENTAL
Intervention: 5% curcumin oral paste three times a day for four weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0.1% triamcinolone three times a day for four weeks
Number of subjects: 50
Study: 23322191

Group type: EXPERIMENTAL
Intervention: Epidural methadone 2.5 mg with 40 mg lidocaine
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Epidural methadone 5 mg with 40 mg lidocaine
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Epidural methadone 7.5 mg with 40 mg lidocaine and 10 mg dexamethasone
Number of subjects: 72
Study: 21844743

Group type: EXPERIMENTAL
Intervention: Episodic acyclovir therapy
Number of subjects: 615

Group type: COMPARATOR
Intervention: Previous care seekers
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Delay in health care seeking
Number of subjects: 615
Study: 18274504

Group type: EXPERIMENTAL
Intervention: Component Model of Reading (CMR) based reading instruction program over 7 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Discrepancy model of learning disabilities
Number of subjects: 0
Study: 16281062

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 351

Group type: COMPARATOR
Intervention: Irbesartan 150 mg
Number of subjects: 351
Study: 14690098

Group type: EXPERIMENTAL
Intervention: Indomethacin 50 mg
Number of subjects: 200

Group type: COMPARATOR
Intervention: Meloxicam 15 mg
Number of subjects: 200
Study: 10719650

Group type: EXPERIMENTAL
Intervention: Intra-arterial thrombolytic therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous thrombolysis
Number of subjects: 0
Study: 8605558

Group type: EXPERIMENTAL
Intervention: Alprostadil (0.6 microgram/kg/hour for five days)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Alprostadil and Placebo (both groups)
Number of subjects: 21
Study: 1419943

Group type: EXPERIMENTAL
Intervention: 28-gauge nylon catheter
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 32-gauge polyurethane catheter
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 32-gauge polyimide catheter
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 28-gauge polyurethane catheter
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Microscopic examination of all catheters
Number of subjects: 41
Study: 4087290

Group type: EXPERIMENTAL
Intervention: Type A winners
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Type A losers
Number of subjects: 24

Group type: COMPARATOR
Intervention: Type B winners and losers
Number of subjects: 24
Study: 30853042

Group type: EXPERIMENTAL
Intervention: Sleep health program (4 weekly group sessions)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Waiting control group
Number of subjects: 63
Study: 29740768

Group type: EXPERIMENTAL
Intervention: 12 t ha-1 CPM
Number of subjects: 0

Group type: COMPARATOR
Intervention: Recommended dose of NPK (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low irrigation regimes (I1 and I2)
Number of subjects: 0
Study: 26250435

Group type: EXPERIMENTAL
Intervention: Iron isomaltoside 1000 (IV)
Number of subjects: 351

Group type: COMPARATOR
Intervention: Oral iron (iron sulphate, 200 mg daily for 8 weeks)
Number of subjects: 351
Study: 24941286

Group type: EXPERIMENTAL
Intervention: Out of School Nutrition and Physical Activity (OSNAP) intervention
Number of subjects: 20
Study: 22990269

Group type: EXPERIMENTAL
Intervention: High-dose aerobic training (40 min/d; n = 73)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Low-dose aerobic training (20 min/d; n = 71)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Control (usual physical activity; n = 78)
Number of subjects: 222
Study: 19295388

Group type: EXPERIMENTAL
Intervention: Halothane anesthesia with nitrous oxide
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia with nitrous oxide
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia with nitrous oxide
Number of subjects: 30

Group type: COMPARATOR
Intervention: Halothane anesthesia with air/oxygen
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isoflurane anesthesia with air/oxygen
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sevoflurane anesthesia with air/oxygen
Number of subjects: 30
Study: 17439905

Group type: EXPERIMENTAL
Intervention: Fampridine-SR (10 to 40 mg twice daily, increasing in 5 mg increments weekly)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 15055251

Group type: EXPERIMENTAL
Intervention: Bedtime administration of trandolapril
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Morning administration of trandolapril
Number of subjects: 37
Study: 12453029

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Divalproex sodium
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 9695314

Group type: EXPERIMENTAL
Intervention: ipriflavone 600 mg/day (OSTEN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: elcatonin 20 IU/week (CT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: daily oral administration of 2 g calcium lactate and 0.5 microgram alphacalcidol (Ca.D)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: repeated 14‐week cycle of daily oral administration of 2 micrograms alphacalcidol for 2 weeks, 600 mg of ipriflavone for 4 weeks, and 2 g calcium lactate together with 0.5 microgram alphacalcidol for 8 weeks (ADFR)
Number of subjects: 0
Study: 9745809

Group type: EXPERIMENTAL
Intervention: 0.1% indomethacin
Number of subjects: 61

Group type: COMPARATOR
Intervention: 0.1% diclofenac
Number of subjects: 61
Study: 1938312

Group type: EXPERIMENTAL
Intervention: Ambient temperature at 20 degrees C
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Ambient temperature at 25-26 degrees C
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Ambient temperature at 30 degrees C
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control for end tidal carbon dioxide measurements
Number of subjects: 54
Study: 7197963

Group type: EXPERIMENTAL
Intervention: Formulation 1 (standard formulation)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Formulation 2 (test formulation)
Number of subjects: 4
Study: 31958547

Group type: EXPERIMENTAL
Intervention: Contrapposto pose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral standing pose
Number of subjects: 0
Study: 30653262

Group type: EXPERIMENTAL
Intervention: PSA screening (cut-off of 4.0 ng/ml), 2-3 screening rounds offered
Number of subjects: 81849

Group type: EXPERIMENTAL
Intervention: Intention-to-screen analysis
Number of subjects: 81849

Group type: COMPARATOR
Intervention: Control arm (no PSA screening)
Number of subjects: 81849
Study: 28143496

Group type: EXPERIMENTAL
Intervention: Advice and paracetamol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Advice and diclofenac
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Advice and placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Advice only (usual care)
Number of subjects: 0
Study: 23295789

Group type: EXPERIMENTAL
Intervention: Chlorambucil plus rituximab (arm B)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Chlorambucil (arm A)
Number of subjects: 227
Study: 20971822

Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin (40 mg/m(2)) and standard vincristine (2 mg) on day 1, followed by dexamethasone and a second cycle at day 28, reinforced by cyclophosphamide
Number of subjects: 60

Group type: COMPARATOR
Intervention: Continuous-infusion doxorubicin (12 mg/m(2)/day) and continuous-infusion vincristine (0.4 mg/day) on days 1-4
Number of subjects: 60
Study: 19827483

Group type: EXPERIMENTAL
Intervention: Modern dressings
Number of subjects: 0
Study: 17082518

Group type: EXPERIMENTAL
Intervention: Flow chart regarding the management of blood and body fluid exposures (Group B)
Number of subjects: 1120

Group type: EXPERIMENTAL
Intervention: E-mail alert containing the flow chart (Group C)
Number of subjects: 1120

Group type: EXPERIMENTAL
Intervention: Oral presentation of information in the flow chart (Group D)
Number of subjects: 1120

Group type: COMPARATOR
Intervention: Face to face training (Group A - control)
Number of subjects: 1120
Study: 15645954

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 21

Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 21
Study: 11358727

Group type: EXPERIMENTAL
Intervention: Twice daily treatment of dithranol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Thrice weekly treatment of dithranol
Number of subjects: 16
Study: 9298911

Group type: EXPERIMENTAL
Intervention: Penicillin, tobramycin, and clindamycin
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Penicillin, tobramycin, and ornidazole
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Piperacillin alone
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ceftriaxone and ornidazole
Number of subjects: 200
Study: 8362531

Group type: EXPERIMENTAL
Intervention: hGH (8 IU) plus HPN (1.0-1.5 g protein/kg/day and 900 kcal/day)
Number of subjects: 180

Group type: COMPARATOR
Intervention: HPN only (control group)
Number of subjects: 180
Study: 3017596

Group type: EXPERIMENTAL
Intervention: Nabilone (1 mg)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Domperidone (20 mg)
Number of subjects: 38
Study: 30184091

Group type: EXPERIMENTAL
Intervention: Higher intake of Ï‰‐6 PUFAs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ï‰‐6 PUFAs
Number of subjects: 0
Study: 27894461

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 139
Study: 24104875

Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg b.i.d. for 7 days)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 110
Study: 23184077

Group type: EXPERIMENTAL
Intervention: Hydration with sodium bicarbonate
Number of subjects: 301

Group type: COMPARATOR
Intervention: Hydration with 0.9% saline
Number of subjects: 301
Study: 20352618

Group type: EXPERIMENTAL
Intervention: Mediterranean-style diet with high intake of virgin olive oil (MD+VOO)
Number of subjects: 737

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 737
Study: 18999171

Group type: EXPERIMENTAL
Intervention: Treatment results distributed via email to collaborating institutions, with blinded recipients not notified of the subject's treatment selection.
Number of subjects: 0
Study: 16043737

Group type: EXPERIMENTAL
Intervention: Low-dose parenteral insulin (human ultralente insulin at 0.25 units x kg(‐1) x day(‐1))
Number of subjects: 100
Study: 11973483

Group type: EXPERIMENTAL
Intervention: Tinnitus patients (n=27)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Non-tinnitus patients (n=18)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Healthy controls (n=26)
Number of subjects: 45
Study: 10209851

Group type: EXPERIMENTAL
Intervention: Ultracision (UC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Clips/EndoGIA
Number of subjects: 20
Study: 7726819

Group type: EXPERIMENTAL
Intervention: Social skills training program (6-week protocol involving positive reinforcement, modeling, rehearsal, feedback, and time out)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Regular classroom activities (Control group)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Social validity assessment via teachers' ratings of videotapes of pretest and posttest assessments
Number of subjects: 32
Study: 1684872

Group type: EXPERIMENTAL
Intervention: Diazepam (0.12 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ondansetron (0.24 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 0
Study: 6760660

Group type: EXPERIMENTAL
Intervention: Piloplex 3.4% b.i.d.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pilocarpine 2.0% q.i.d.
Number of subjects: 0
Study: 31256846

Group type: EXPERIMENTAL
Intervention: Mechanical vibration
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 28102437

Group type: EXPERIMENTAL
Intervention: Standard endurance and strength training (SET)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Medical Qigong (QG)
Number of subjects: 19
Study: 27681404

Group type: EXPERIMENTAL
Intervention: Single-visit pulpectomy with zinc oxide eugenol (ZOE)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Two-visit pulpectomy with intracanal calcium hydroxide followed by obturation with ZOE
Number of subjects: 64